Memphasys Ltd has released a press release.
Extension of Convertible Notes
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Memphasys
- Felix Data lock complete and regulatory submission commenced
- Leading Brazilian Andrology Clinic to test Felix System
- Felix Clinical Trial complete, Data Lock expected in 2 weeks
- Publication Highlights Diagnostic Potential of RoXsta TM
- Heranova Felix System Utilisation Testing commences in China
Later from Memphasys
- Half Yearly Report and Accounts
- Felix Trial Confirms Best-in-Class Performance
- RoXsta offers Effective Oxidative Stress Measurem't 4 Cattle
- Pause in Trading
- $1.275M Placement to Accelerate Commercial Rollout
Follow Memphasys into a list and get an email when it puts out news.
Follow Memphasys